Financials in USD. Standardized financial statements.
A compact view of how Apollo Endosurgery, Inc. turns revenue into operating income and net income.
| Metric | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $76.86M | $62.99M | $42.05M | $50.71M | $60.85M | $64.31M | $64.87M | $1.60M | $5.08M | $7.99M |
| Revenue Growth? | +22.0% | +49.8% | -17.1% | -16.7% | -5.4% | -0.9% | +3954.9% | -68.5% | -36.4% | 0.0% |
| Cost of Revenue? | $34.43M | $28.03M | $19.81M | $25.04M | $27.66M | $24.58M | $25.25M | $0 | $0 | $0 |
| Gross Profit? | $42.43M | $34.96M | $22.24M | $25.68M | $33.19M | $39.73M | $39.61M | $1.60M | $5.08M | $7.99M |
| Gross Margin? | +55.2% | +55.5% | +52.9% | +50.6% | +54.5% | +61.8% | +61.1% | +100.0% | +100.0% | +100.0% |
| Operating Expenses? | $70.25M | $54.16M | $38.04M | $54.80M | $65.52M | $62.17M | $60.37M | $12.46M | $22.89M | $15.58M |
| Operating Income? | -$27.82M | -$19.20M | -$15.79M | -$29.12M | -$40.09M | -$22.44M | -$20.76M | -$10.86M | -$17.81M | -$7.59M |
| EBITDA? | -$31.42M | -$14.19M | -$11.88M | -$26.21M | -$40.09M | -$12.76M | -$20.76M | -$9.54M | -$17.81M | -$7.59M |
| Income Before Tax | -$39.26M | -$24.53M | -$22.47M | -$27.16M | -$45.60M | -$26.99M | -$40.78M | -$10.01M | -$16.56M | -$6.56M |
| Income Tax Expense | $584,000 | $156,000 | $142,000 | $275,000 | $191,000 | $304,000 | $387,000 | $0 | $0 | $0 |
| Net Income? | -$39.84M | -$24.68M | -$22.61M | -$27.43M | -$45.79M | -$27.29M | -$41.17M | -$10.01M | -$16.56M | -$6.56M |
| EPS? | $-0.98 | $-0.82 | $-0.99 | $-1.27 | $-2.31 | $-2.01 | $-105.69 | $-29.95 | $-77.00 | $-37.61 |
| Diluted EPS? | $-0.98 | $-0.82 | $-0.99 | $-1.27 | $-2.31 | $-2.01 | $-105.69 | $-29.95 | $-77.00 | $-37.61 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality